Nuclear run-on assay indicated that stable over-expression or knockdown of Smad4 decreased or increased the nascent transcript levels of HPSE in NB cells, respectively (Supplementary Fig. S2a). This evidence concerns the gene SMAD4 and neuroblastoma.